Publicaciones en colaboración con investigadores/as de University of Texas Health Science Center at San Antonio (23)

2024

  1. The OPTIFAST total and partial meal replacement programme reduces cardiometabolic risk in adults with obesity: Secondary and exploratory analysis of the OPTIWIN study

    Diabetes, Obesity and Metabolism, Vol. 26, Núm. 3, pp. 950-960

2022

  1. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  2. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2021

  1. Decline in subarachnoid haemorrhage volumes associated with the first wave of the COVID-19 pandemic

    Stroke and Vascular Neurology, Vol. 6, Núm. 4, pp. 542-552

2020

  1. The urgent need for integrated science to fight COVID-19 pandemic and beyond

    Journal of Translational Medicine, Vol. 18, Núm. 1

2019

  1. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial

    The Lancet, Vol. 393, Núm. 10175, pp. 1021-1032

2018

  1. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study

    Intensive Care Medicine, Vol. 44, Núm. 9, pp. 1470-1482

2012

  1. Microwave and magnetic (M2) proteomics of the experimental autoimmune encephalomyelitis animal model of multiple sclerosis

    Electrophoresis, Vol. 33, Núm. 24, pp. 3810-3819

2010

  1. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: Implications for risk prediction

    Cancer Research, Vol. 70, Núm. 23, pp. 9742-9754

2006

  1. Inhibition of neuronal nitric oxide synthase activity by N 1-acetyl-5-methoxykynuramine, a brain metabolite of melatonin

    Journal of Neurochemistry, Vol. 98, Núm. 6, pp. 2023-2033

2001

  1. Endogenous rhythms of melatonin, total antioxidant status and superoxide dismutase activity in several tissues of chick and their inhibition by light

    Journal of Pineal Research, Vol. 30, Núm. 4, pp. 227-233

2000

  1. Genotoxicity of paraquat: Micronuclei induced in bone marrow and peripheral blood are inhibited by melatonin

    Mutation Research - Genetic Toxicology and Environmental Mutagenesis, Vol. 464, Núm. 2, pp. 239-245

1998

  1. Rhythms of glutathione peroxidase and glutathione reductase in brain of chick and their inhibition by light

    Neurochemistry International, Vol. 32, Núm. 1, pp. 69-75

1997

  1. Acutely administered melatonin reduces oxidative damage in lung and brain induced by hyperbaric oxygen

    Journal of Applied Physiology, Vol. 83, Núm. 2, pp. 354-358

  2. Melatonin prevents increases in neural nitric oxide and cyclic GMP production after transient brain ischemia and reperfusion in the Mongolian gerbil (Meriones Unguiculatus)

    Journal of Pineal Research, Vol. 23, Núm. 1, pp. 24-31

1996

  1. Melatonin in the context of the free radical theory of aging

    Annals of the New York Academy of Sciences

  2. Nocturnal decreases in nitric oxide and cyclic GMP contents in the chick brain and their prevention by light

    Neurochemistry International, Vol. 29, Núm. 4, pp. 417-421

1995

  1. Melatonin counteracts lipid peroxidation induced by carbon tetrachloride but does not restore glucose‐6 phosphatase activity

    Journal of Pineal Research, Vol. 19, Núm. 1, pp. 1-6

  2. Melatonin stimulates brain glutathione peroxidase activity

    Neurochemistry International, Vol. 26, Núm. 5, pp. 497-502

  3. Melatonin stimulates the activity of the detoxifying enzyme glutathione peroxidase in several tissues of chicks

    Journal of Pineal Research, Vol. 19, Núm. 3, pp. 111-115